Related Experiment Video
Updated: Jul 26, 2025

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Metabolic syndrome as risk factor for left ventricular hypertrophy in children with chronic kidney disease
Monika Drożdż1, Anna Moczulska1, Andrzej Rudziński2
1Department of Pediatric Nephrology and Hypertension, Jagiellonian University Medical College, Kraków, Poland.
Insights
Metabolic syndrome (MS) and hypertension are key risk factors for left ventricular hypertrophy (LVH) in children with chronic kidney disease (CKD). Growth deficit also significantly contributes to LVH development in this vulnerable population.
Area of Science:
- Pediatric Nephrology
- Cardiology
- Metabolic Disorders
Background:
- Metabolic syndrome (MS) is prevalent in children with chronic kidney disease (CKD).
- Left ventricular hypertrophy (LVH) is a significant cardiovascular risk in CKD patients.
- Identifying LVH risk factors in pediatric CKD is crucial for cardiovascular risk management.
Purpose of the Study:
- To determine the most significant risk factors for left ventricular hypertrophy (LVH) in children suffering from chronic kidney disease (CKD).
Main Methods:
- 71 children with CKD stages 1-5 underwent evaluation.
- Metabolic syndrome (MS) diagnosed using De Ferranti (DF) criteria.
- Echocardiography, ambulatory blood pressure monitoring (ABPM), and laboratory tests were performed.
Main Results:
- Left ventricular hypertrophy (LVH) was detected in 29.6% of the children.
- Metabolic syndrome (MS) diagnosis (OR=24.11), high mean arterial pressure (MAP SDS) (OR=2.812), and low height SDS (OR=0.078) were significant predictors of LVH.
- CKD stage 5 and low height SDS were strongest univariate risk factors.
Conclusions:
- Metabolic syndrome (MS), hypertension, advanced CKD stage, and growth deficit are significant contributors to LVH in pediatric CKD.
- These findings highlight the multifactorial nature of LVH in children with CKD.
Background:
The metabolic syndrome (MS), a cluster of clinical and biochemical abnormalities including insulin resistance, dyslipidemia and hypertension, is often diagnosed in chronic kidney disease (CKD) children. Left ventricular hypertrophy (LVH) is a major target organ damage in hypertension and an important cardiovascular risk factor in CKD patients. We aimed to identify the most significant risk factors of LVH in children with CKD.
Methods:
Children with CKD stage 1-5 were enrolled in the study. MS was diagnosed according to De Ferranti (DF) as ≥3 from 5 criteria. Ambulatory blood pressure measurements (ABPM) and echocardiographic evaluation were performed. LVH was defined as ≥95th percentile of LV mass index related to height and age. Clinical and laboratory parameters included: serum albumin, Ca, HCT, cystatin C, creatinine, estimated glomerular filtration rate (eGFR) based on Schwartz formula, triglycerides, high-density lipoprotein (HDL), proteinuria, BMI standard deviation score (SDS), height SDS, waist circumference, ABPM data.
Results:
71 children (28 girls/43 boys) with median age 14.05 (25%-75%:10.03-16.30) years and median eGFR 66.75 (32.76-92.32) ml/min/1.73m2 were evaluated. CKD stage 5 was diagnosed in 11 pts (15.5%). MS (DF) was diagnosed in 20 pts (28.2%). Glucose ≥ 110 mg/dL was present in 3 pts (4.2%); waist circumference ≥75th pc in 16 pts (22.5%); triglycerides ≥ 100 mg/dL in 35 pts (49.3%); HDL < 50mg/dL in 31 pts (43.7%) and BP ≥ 90th pc in 29 pts (40.8%), respectively. LVH was detected in 21 (29.6%) children. In univariate regression the strongest risk factor for LVH was CKD stage 5 (OR 4.9, p=0.0019) and low height SDS (OR 0.43,p=0.0009). In stepwise multiple logistic regression analysis (logit model) of the most important risk factors for LVH in CKD children, only three were statistically significant predictors: 1)MS diagnosis based on DF criteria (OR=24.11; 95%CI 1.1-528.7; p=0.043; Chi2 = 8.38,p=0.0038); 2), high mean arterial pressure (MAP SDS) in ABPM (OR=2.812; 95%CI 1.057-7.48; p=0.038;Chi2 = 5.91, p=0.015) and 3) low height SDS (OR=0.078; 95%CI 0.013-0.486;p=0.006; Chi2 = 25.01, p<0.001).
Conclusions:
In children with chronic kidney disease LVH is associated with the cluster of multiple factors, among them the components of MS, hypertension, stage 5 CKD and growth deficit were the most significant.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Heart Failure II: Pathophysiology
Mitral Regurgitation I: Introduction
Chronic Kidney Disease IV: Nursing Management

